Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HSCT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06572462
What this trial is testing

ATG Individualized Dosing Model in URD-PBSCT.

Who this might be right for
Cytomegalovirus InfectionsInfection ReactivationStem Cell Transplant Complications
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00992446
What this trial is testing

Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Diffuse Large B-Cell LymphomaB-Cell Non-Hodgkin LymphomaFollicular Lymphoma+3 more
Fred Hutchinson Cancer Center 27
Early research (Phase 1)Study completedNCT00005946
What this trial is testing

Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Early research (Phase 1)Not Yet RecruitingNCT07350057
What this trial is testing

A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children

Who this might be right for
GVHD (Acute or Chronic)
Shanghai Jiao Tong University School of Medicine 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05303727
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

Who this might be right for
Neuroblastoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 64
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Early research (Phase 1)Study completedNCT02065596
What this trial is testing

Hematopoietic Stem Cell Transplant for Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell AnemiaSCD
Case Comprehensive Cancer Center 4
Early research (Phase 1)Ended earlyNCT00725062
What this trial is testing

Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Looking for participantsNCT04991103
What this trial is testing

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

Who this might be right for
Multiple MyelomaAmyloidosis
University of Alabama at Birmingham 40
Not applicableLooking for participantsNCT07500441
What this trial is testing

Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Peking University People's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00768066
What this trial is testing

The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT)

Who this might be right for
Stem Cell TransplantationVentricular Dysfunction, Left
University of Miami 65
Not applicableStudy completedNCT02257905
What this trial is testing

Allo SCT in Amyloidosis Non-interventional Study

Who this might be right for
AL Amyloidosis
European Society for Blood and Marrow Transplantation 14
Large-scale testing (Phase 3)Study completedNCT01827605
What this trial is testing

A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

Who this might be right for
Relapsed Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 159
Testing effectiveness (Phase 2)UnknownNCT02568241
What this trial is testing

Interferon-α After DLI for the Prevention of Relapse

Who this might be right for
Leukemia
Peking University People's Hospital 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT02782546
What this trial is testing

Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Washington University School of Medicine 60
Large-scale testing (Phase 3)Looking for participantsNCT07583888
What this trial is testing

VABu Conditioning in Elderly AML HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientAcute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University 20
Early research (Phase 1)Study completedNCT00383994
What this trial is testing

Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation

Who this might be right for
LymphomaLeukemiaTransplantation, Stem Cell+2 more
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT03356054
What this trial is testing

Phase I-II Study in CD30 Positive Diffuse Large B-cell Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse

Who this might be right for
DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland 37
Not applicableStudy completedNCT03342586
What this trial is testing

Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity

Who this might be right for
Central Nervous System Lymphoma
Memorial Sloan Kettering Cancer Center 14
Not applicableStudy completedNCT00186342
What this trial is testing

Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

Who this might be right for
Acute DiseaseMyelodysplastic SyndromesLeukemia, Myeloid, Chronic+4 more
Stanford University 120
Next Page